2008Chinese Clinical OncologyRequires access

Study on mechanism of apoptosis induced by Ara-C in leukemia HL-60 cells

Ya Wang

Open publisher page 0 citations

Abstract

Objective:To explore the machanism of apoptosis induced by Ara-C in HL-60 cells.Methods:Cell viability was determined by trypan blue exclusion,the growth inhibition was analyzed by MTT assay;cell apoptosis by morphology and flow cytometry;Bcl-2 and caspase-3 by western blot.Results:Ara-C(1-100μM)inhibited cellular proliferation and induced apoptosis and reducde the levels of Bcl-2 proteins and activated caspase-3 in a dose and time dependent fashion in HL-60 cells.PD98059(25μM)(a inhibitor of MEK)enhanced apoptosis and activity of caspase-3 induced by Ara-C without altering Bcl-2 protein.However,SB203580(20μM)(a inhibitor of P38MAPK)reduced the apoptosis and activity of caspase-3 induced by Ara-C without altering Bcl-2 protein.SP600125(a inhibitor of JNK)did not affected effects of Ara-C.Conclusion:Ara-C downregulates Bcl-2 and activates caspase-3 during apoptosis in HL-60 cells;a inhibitor of MEK enhances apoptosis induced by Ara-C.However,a inhibitor of P38MAPK reduces the effects of Ara-C in HL-60 cells.

About this research paper

What this paper is about

Objective:To explore the machanism of apoptosis induced by Ara-C in HL-60 cells.Methods:Cell viability was determined by trypan blue exclusion,the growth inhibition was analyzed by MTT assay;cell apoptosis by morphology and flow cytometry;Bcl-2 and caspase-3 by western blot.Results:Ara-C(1-100μM)inhibited cellular proliferation and induced apoptosis and reducde the levels of Bcl-2 proteins and activated caspase-3 in a dose and time dependent fashion in HL-60 cells.PD98059(25μM)(a inhibitor of MEK)enhanced apoptosis and activity of caspase-3 induced by Ara-C without altering Bcl-2 protein.However,SB203580(20μM)(a inhibitor of P38MAPK)reduced the apoptosis and activity of caspase-3 induced by Ara-C without altering Bcl-2 protein.SP600125(a inhibitor of JNK)did not affected effects of Ara-C.Conclusion:Ara-C downregulates Bcl-2 and activates caspase-3 during apoptosis in HL-60 cells;a inhibitor of MEK enhances apoptosis induced by Ara-C.However,a inhibitor of P38MAPK reduces the effects of Ara-C in HL-60 cells.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To explore the machanism of apoptosis induced by Ara-C in HL-60 cells.Methods:Cell viability was determined by trypan blue exclusion,the growth inhibition was analyzed by MTT assay;cell apoptosis by morphology and flow cytometry;Bcl-2 and caspase-3 by western blot.Results:Ara-C(1-100μM)inhibited cellular proliferation and induced apoptosis and reducde the levels of Bcl-2 proteins and activated caspase-3 in a dose and time dependent fashion in HL-60 cells.PD98059(25μM)(a inhibitor of MEK)enhanced apoptosis and activity of caspase-3 induced by Ara-C without altering Bcl-2 protein.However,SB203580(20μM)(a inhibitor of P38MAPK)reduced the apoptosis and activity of caspase-3 induced by Ara-C without altering Bcl-2 protein.SP600125(a inhibitor of JNK)did not affected effects of Ara-C.Conclusion:Ara-C downregulates Bcl-2 and activates caspase-3 during apoptosis in HL-60 cells;a inhibitor of MEK enhances apoptosis induced by Ara-C.However,a inhibitor of P38MAPK reduces the effects of Ara-C in HL-60 cells.

Key concepts: Apoptosis, Trypan blue, Western blot, Flow cytometry, Molecular biology, Viability assay, MTT assay, Inhibitor of apoptosis domain

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on mechanism of apoptosis induced by Ara-C in leukemia HL-60 cells — Research Paper | ScholarLens